The Jakarta Post
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search results
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search resultsVaccine safety, effectiveness must be ensured: Jokowi
“Because if not – if there’s even one problem – it will create public distrust in the vaccination effort,” he said.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Set as preferred source
P
resident Joko “Jokowi” Widodo has instructed his Cabinet to ensure the safety and effectiveness of the COVID-19 vaccines to be used in the national vaccination program.
The two issues were the top concerns of experts and the public, he said.
“Safety means that all vaccines given to people must first go through a series of proper clinical trials,” the president said during a limited Cabinet meeting at Merdeka Palace on Monday. “Because if not – if there’s even one problem – it will create public distrust in the vaccination effort.”
Each stage of the trials, he said, must be based on scientific processes and data, as well as proper health standards. He warned his Cabinet not to let excessive haste jeopardize the testing process.
“Be careful, and don’t rush for a vaccine and overlook health standards,” he said.
Previously, the Indonesian Medical Association (IDI), the Indonesian Society of Internal Medicine (PAPDI) and several other associations warned the government not to rush into the COVID-19 vaccination program as the government pushed for emergency use authorization for several COVID-19 candidate vaccines still under development.
Experts said the government was betting on the success of unfinished vaccines to solve the COVID-19 crisis in the country.
